FuFangDanShen vs 'no treatment'
Global performance (improved) ‐ not measured · People with vascular dementia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
The review found no eligible studies for this question.
FuFangDanShen showed no clear difference in adverse events (AEs) (1 or more) compared with 'no treatment' (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.